83 completed, 41 unknown, 15 terminated, 13 withdrawn. 38 Phase 2, 26 Phase 3, 21 Not applicable, 16 Phase 1, 4 Phase 4.
Follow SARS-CoV2: new trials by email Literature Review of SARS-CoV2 trials Research Report on SARS-CoV2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3 - SARS-CoV2, COVID-19 | Phase 2 | Active not recruiting | Vaxart | 5485 | 2024-10-08 | 2026-10-09 |
| Risk of Air Contamination During Visceral Surgery in COVID19 Patients Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients. - Sars-CoV2, Surgery | Not applicable | Completed | University Hospital, Lille | 2 | 2021-11-16 | 2025-12-23 |
| TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 Peginterferon Lambda-1A, Placebo - Sars-CoV2, Covid19 | Phase 3 | Unknown | University Health Network, Toronto | 763 | 2021-08-27 | 2022-04-05 |
| Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave. SARS-CoV2 | Unknown | Cairo University | 345 | 2021-05-25 | 2021-06-16 | |
| Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit Intensive Care Unit, SARS-CoV2 | Unknown | Assistance Publique - Hôpitaux de Paris | 264 | 2021-04-27 | 2021-05-17 | |
| Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 Ribavirin Capsules, Favipiravir - SARS-CoV2, COVID-19 | Phase 2 / Phase 3 | Unknown | The Scientific and Technological Research Council of Turkey | 100 | 2021-04-01 | 2021-04-02 |
| Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS Rapamycin, Placebo - Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure | Phase 1 / Phase 2 | Withdrawn | The University of Texas Health Science Center at San Antonio | 2021-04-01 | 2021-06-01 | |
| Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19 Resistance training, Standard care - Covid19, SARS-CoV2 | Not applicable | Completed | Universidad Pública de Navarra | 100 | 2021-03-08 | 2022-11-02 |
| Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) Mesenchymal Stromal Cells, Supportive Care - Sars-CoV2, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Baylor College of Medicine | 28 | 2021-02-12 | 2026-10-21 |
| Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2 | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 32 | 2020-12-09 | 2022-02-11 |
| Trial of Combination Therapy to Treat COVID-19 Infection Ivermectin, Doxycycline Hcl, Zinc - COVID, Covid-19 | Phase 1 | Completed | ProgenaBiome | 31 | 2020-12-09 | 2024-09-24 |
| Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients Ivermectin Injectable Solution, Injectable Placebo, Zinc - Coronavirus Infection, COVID | Phase 1 / Phase 2 | Unknown | Sohaib Ashraf | 180 | 2020-11-14 | 2021-02-17 |
| Methylene Blue Treatment of COVID-19 Methylene Blue, Control Test - SARS-CoV2 | Phase 2 | Completed | Fondazione Epatocentro Ticino | 29 | 2020-11-05 | 2025-08-17 |
| Anti-Androgen Treatment for COVID-19 Proxalutamide, Standard of Care - COVID-19, SARS-CoV2 | Not applicable | Completed | Applied Biology, Inc. | 268 | 2020-10-21 | 2021-12-10 |
| LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) LSALT peptide, Placebo - COVID, Severe Acute Respiratory Syndrome | Phase 2 | Completed | Arch Biopartners Inc. | 61 | 2020-10-14 | 2025-07-09 |
| Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection SARS-CoV2, COVID | Unknown | Medecins Sans Frontieres, Spain | 600 | 2020-10-01 | 2021-10-01 | |
| Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 Linagliptin 5 MG - COVID 19, Coronavirus | Phase 3 | Terminated | Rabin Medical Center | 64 | 2020-10-01 | 2021-06-02 |
| Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Defibrotide - COVID, Sars-CoV2 | Phase 1 | Completed | Gregory Yanik | 13 | 2020-10-01 | 2023-05-09 |
| SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) Blood test antibodies against SARS-CoV-2 - SARS-Cov2 | Unknown | University of Erlangen-Nürnberg Medical School | 7000 | 2020-10-01 | 2022-01-27 | |
| Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers Previfenon®, Placebo - COVID-19, SARS-CoV2 | Phase 2 / Phase 3 | Withdrawn | MELISA Institute Genomics & Proteomics Research SpA | 2020-09-30 | 2026-10-19 |
Showing 20 of 160. Sign in to see all of them.
COVID-19 (107) · Coronavirus Infections (33) · Respiratory Distress Syndrome (13) · Severe Acute Respiratory Syndrome (8) · Pneumonia (6) · Thrombosis (5) · Critical Illness (4) · Virus Diseases (4) · Acute Lung Injury (3) · Anxiety Disorders (3) · Chronic Pain (3) · Disease (3) · Infections (3) · Neoplasms (3) · Pneumonia, Viral (3)
Coronaviridae Infections (117) · Infections (117) · Nidovirales Infections (117) · RNA Virus Infections (117) · Virus Diseases (114) · Respiratory Tract Diseases (111) · Lung Diseases (110) · Respiratory Tract Infections (110) · Pneumonia, Viral (104) · Pneumonia (102) · Coronavirus Infections (84) · Pathological Conditions, Signs and Symptoms (21) · Pathologic Processes (16) · Respiration Disorders (13) · Cardiovascular Diseases (9)
Hydroxychloroquine (11) · Zinc (5) · Azithromycin (4) · Saline Solution (4) · Standard of Care (4) · Surveys and Questionnaires (4) · Ascorbic Acid (3) · Blood Specimen Collection (3) · COVID-19 Serotherapy (3) · COVID-19 Testing (3) · Enoxaparin (3) · Ivermectin (3) · favipiravir (3) · Heparin (2) · Respiratory Function Tests (2)
University Hospital, Lille (14) · Assistance Publique - Hôpitaux de Paris (6) · ProgenaBiome (4) · Direction Centrale du Service de Santé des Armées (3) · University Hospital, Strasbourg, France (3) · Centre Hospitalier Universitaire de Besancon (2) · Centre Hospitalier Universitaire de Saint Etienne (2) · Centre Hospitalier Universitaire, Amiens (2) · Deborah O'Connor (2) · Medical University of Vienna (2) · Northwell Health (2) · SAb Biotherapeutics, Inc. (2) · Sohaib Ashraf (2) · Szeged University (2) · Universitair Ziekenhuis Brussel (2)
France (49) · United States (38) · Brazil (8) · Spain (8) · Canada (7) · Italy (7) · Belgium (5) · Germany (5) · Turkey (Türkiye) (5) · Switzerland (4) · Pakistan (3) · Sweden (3) · Colombia (2) · Hungary (2) · Mexico (2)
Sabine Hazan, MD (4) · David Hoover, MD (2) · Jordan Feld, MD (2) · Saad Nseir, MD,PhD (2) · Shoaib Ashraf, PhD (2) · Sohaib Ashraf, MBBS (2) · Aaron Nizam, MD (1) · Adel El Bardissy (1) · Alex C Spyropoulos, MD (1) · Ammar Sarwar, MD (1) · Anders Kjellberg, MD (1) · Andrei Y Hancharou, Dr. (1) · Andy Goren, MD (1)
PMID 34473343, PMID 33502773, PMID 35244208, PMID 31986264, PMID 31995857, PMID 32014114, PMID 32109013, PMID 32209891, PMID 32234250, PMID 32241022, PMID 32242095, PMID 32259322, PMID 32259546, PMID 32292899, PMID 32314249, PMID 32336042, PMID 32379329, PMID 32381426, PMID 32407672, PMID 32555385, PMID 32569585, PMID 32788708, PMID 33050924, PMID 33268442, PMID 33293316, PMID 33430924, PMID 33435887, PMID 33556319, PMID 33571450, PMID 33591017, PMID 33621601, PMID 33624010, PMID 33627169, PMID 33754144, PMID 33786454, PMID 33887208, PMID 33941622, PMID 33982128, PMID 33987718, PMID 34081073, PMID 34135471, PMID 34174393, PMID 34187698, PMID 34226219, PMID 34350193, PMID 34374951, PMID 34488858, PMID 34521667, PMID 34543753, PMID 34617959
P30CA225520 (1), P51OD011106 (1)